GlaxoSmithKline News

6-K: Gsk on track to deliver 2024 outlooks with further good progress made in r&d

Oct 30 23:27

6-K: Gsk Delivers Continued Strong Performance and Upgrades 2024 Guidance

Aug 1 00:31

6-K: Gsk Makes a Strong Start to 2024 with Improving Outlook for the Year

May 2 00:34

GlaxoSmithKline | 6-K: Glaxosmithkline 2023 Annual Report on Form 20-F

Mar 6 02:13

GlaxoSmithKline | 20-F: FY2023 Annual Report

Mar 6 01:18

GlaxoSmithKline | 6-K: Gsk Delivers Strong 2023 Performance and Upgrades Growth Outlooks

Feb 1 02:02

GlaxoSmithKline | 6-K: Strong Year-to-Date and Q3 Performance Drives Upgrade to Full-Year Guidance

Nov 2, 2023 00:51

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 26, 2023 22:56

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 27, 2023 00:01

GlaxoSmithKline | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

Apr 15, 2023 08:35

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 11, 2023 01:16

GlaxoSmithKline | 20-F: FY2022 Annual Report

Mar 11, 2023 00:13

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 1, 2023 22:13

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 3, 2022 00:13

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 28, 2022 00:44

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 2, 2022 00:36

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 27, 2022 23:45

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 9, 2022 03:06

GlaxoSmithKline | 20-F: FY2021 Annual Report

Mar 9, 2022 02:05

GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 28, 2022 23:17